XORTX Therapeutics Inc Financial Overview
XORTX Therapeutics Inc's market cap is currently C$5.81M. The company's EPS TTM is C$-0.1789002319; its P/E ratio is -1.27; XORTX Therapeutics Inc is scheduled to report earnings on November 15, 2025, and the estimated EPS forecast is C$-0.23. See an overview of income statement, balance sheet, and cash flow financials.
